These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16417922)

  • 1. Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome.
    Font P; Subirá D; Mtnez-Chamorro C; Castañón S; Arranz E; Ramiro S; Gil-Fernández JJ; López-Pascual J; Alonso A; Pérez-Sáenz MA; Alaez C; Renedo M; Blas C; Escudero A; Fdez-Rañada JM
    Leuk Res; 2006 Aug; 30(8):957-63. PubMed ID: 16417922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes.
    Satoh C; Tamura H; Yamashita T; Tsuji T; Dan K; Ogata K
    Leuk Res; 2009 Feb; 33(2):326-31. PubMed ID: 18718658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study.
    Ogata K; Kakumoto K; Matsuda A; Tohyama K; Tamura H; Ueda Y; Kurokawa M; Takeuchi J; Shibayama H; Emi N; Motoji T; Miyazaki Y; Tamaki H; Mitani K; Naoe T; Sugiyama H; Takaku F
    Leuk Res; 2012 Oct; 36(10):1229-36. PubMed ID: 22682984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.
    Xu F; Li X; Wu L; He Q; Zhang Z; Chang C
    Br J Haematol; 2010 May; 149(4):587-97. PubMed ID: 20331463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
    Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
    Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
    Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
    Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
    Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
    Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
    Falco P; Levis A; Stacchini A; Ciriello MM; Geuna M; Notari P; Omedè P; Pautasso M; Prato G; Strola G; Gioia D; Bonferroni M; Cametti G; Ferrero D; Freilone R; Gaidano G; Marinone C; Marmont F; Pollio B; Salvi F; Saglio G; Girotto M;
    Eur J Haematol; 2011 Nov; 87(5):409-18. PubMed ID: 21711395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes.
    Cesana C; Klersy C; Brando B; Nosari A; Scarpati B; Scampini L; Molteni A; Nador G; Santoleri L; Formenti M; Valentini M; Mazzone A; Morra E; Cairoli R
    Leuk Res; 2008 Nov; 32(11):1715-23. PubMed ID: 18456323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD7 in myelodysplastic syndromes (MDS): is this a truly prognostic factor?
    Font P; Subirá D
    Leuk Res; 2008 Jan; 32(1):185-6. PubMed ID: 17383724
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia.
    Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox-Froncillo MC; Aronica G; Bruno A; Del Moro B; Epiceno AM; Battaglia A; Forte L; Postorino M; Cordero V; Santinelli S; Amadori S
    Leukemia; 1998 Jul; 12(7):1056-63. PubMed ID: 9665190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry.
    Huh YO; Smith TL; Collins P; Bueso-Ramos C; Albitar M; Kantarjian HM; Pierce SA; Freireich EJ
    Leuk Lymphoma; 2000 Apr; 37(3-4):319-31. PubMed ID: 10752983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia.
    Xu D; Schultz C; Akker Y; Cannizzaro L; Ramesh KH; Du J; Ratech H
    Am J Hematol; 2003 Sep; 74(1):9-16. PubMed ID: 12949884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype.
    Chang H; Yeung J; Brandwein J; Yi QL
    Leuk Res; 2007 Feb; 31(2):157-62. PubMed ID: 16837044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.